TAB3 and breast cancer: MiR-892b over-expression decreased the expression levels of TRAF2, TAB3 and TAK1 in the BC cells and clinical specimens and thus miR-892b functions as a tumor-suppressive miRNA in BC by targeting multiple components in NF-κB cascade [129].